Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …

Objective To evaluate trends in the utilization of stereotactic body radiotherapy (SBRT) and
to compare overall survival (OS) of patients with early-stage non–small cell lung cancer …

Objectives To compare overall survival (OS) and cancer-specific survival (CSS) outcomes of
surgery with radiotherapy in octogenarians with stage Ia non-small cell lung cancer …

Purpose To establish the prognostic significance of C-reactive protein (CRP) and albumin in
octogenarians with non-small cell lung cancer (NSCLC) based on the study of the Japanese …

Background Sampling of≥ 10 lymph nodes during lobectomy for non–small cell lung cancer
(NSCLC) was a previous surveillance metric and potential quality metric of the American …

Simple Summary Lung cancer remains the leading cause of cancer-related mortality
worldwide. Although early-stage non-small cell lung cancer (NSCLC) is likely to be …

Background The coronavirus disease‐19 (COVID‐19) pandemic poses unprecedented
challenges to global healthcare. The contemporary influence of COVID‐19 on the delivery of …

Objective Lobectomy is the standard treatment for patients with early-stage non–small cell
lung cancer (NSCLC). In recent years, an increasing number of patients with lung cancer …

Background As the population ages, there will be an increasing number of octogenarian
patients with non-small cell lung cancer (NSCLC). In carefully selected elderly patients …

Purpose Non-small cell lung cancer is the most common malignancy of the elderly, with 5-
year survival estimates of 16.8%. The prognostic benefit of surgical resection for early lung …